Table 2.
Urinary endoglin normalized to total urinary protein (TP) as a marker for prostate cancer in men at increased risk for prostate cancer (abnormal PSA &/or DRE)
Sensitivity | Specificity | |||
---|---|---|---|---|
Urinary Endoglin/TP Cutoff | ||||
% | 95% CI | % | 95% CI | |
14.8 | 34.3 | (23.1 – 46.9) | 93.7 | (79.1 – 99.2) |
8.9 | 53.7 | (41.1 – 66.0) | 84.3 | (67.2 – 94.7) |
4.0 | 73.1 | (60.9 – 83.2) | 62.5 | (43.6 – 78.9) |
3.1 | 80.6 | (69.1 – 89.2) | 50.0 | (31.8 – 68.1) |
1.9 | 85.0 | (74.2 – 92.6) | 43.8 | (26.3 – 62.3) |